托马斯·哈德逊,医学博士

Dr. Hudson joined AbbVie in 2016, overseeing oncology discovery and early development before assuming responsibilities for the entire discovery organization as Vice President, Discovery Research.  ​

Prior to joining AbbVie, Dr. Hudson was the President and Scientific Director of the Ontario Institute for Cancer Research where he led the institute’s work in translational research for the prevention, detection, diagnosis and treatment of cancer. A Canadian genome scientist, Dr. Hudson was one of the leaders in mapping the human genome and is internationally renowned for his work in genomics, human genome variation and genetic diseases. Dr. Hudson has co-authored more than 300 peer-reviewed scientific publications. He received his M.D. from the University of Montreal.

托马斯·赫德森博士作为AbbVie的高级副总裁,研发和首席科学家。在这个角色,他领导公司的研发组织和全球团队工作在治疗领域的科学家们识别潜在的新的治疗各种各样的疾病。哈德逊博士带领公司研发战略以及许多AbbVie追求科学的伙伴关系。

哈德逊博士于2016年加入AbbVie,监督肿瘤早期发现和发展承担责任之前整个发现组织副总裁发现研究。狗万正网地址

加入AbbVie之前,哈德逊博士是总统和科学安大略癌症研究所的主任,他领导了研究所的工作在转化研究预防、检测、诊断和治疗癌症。加拿大基因组科学家,哈德逊博士是绘制人类基因组图谱的领导人之一,是国际知名的工作在基因组学、人类基因组变异和遗传疾病。哈德逊博士合著的300多名同行评议的科学出版物。他从蒙特利尔大学获得医学学位。